Vanguard Global Advisers »

Lenz Therapeutics shares owned by Vanguard Global Advisers

Quarter-by-quarter ownership of Lenz Therapeutics (LENZ) shares owned by Vanguard Global Advisers from 13F filings

Historical chart of Vanguard Global Advisers investment in Lenz Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Lenz Therapeutics held by Vanguard Global Advisers consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Lenz Therapeutics by Vanguard Global Advisers

Quarter filed Position value Share count Share price at filing
2026-03-31 $79k 8.6k 9.15

More positions owned by Vanguard Global Advisers

Vanguard Index Fds S&p 500 Etf Shs (VOO)
Vanguard Index Fds Total Stk Mkt (VTI)
NVIDIA Corporation (NVDA)
Apple (AAPL)
Microsoft Corporation (MSFT)
Amazon (AMZN)
Alphabet Cap Stk Cl A (GOOGL)
Broadcom (AVGO)
Alphabet Cap Stk Cl C (GOOG)
Vanguard Intl Equity Index F Ftse Emr Mkt Etf (VWO)
Meta Platforms Cl A (META)
Tesla Motors (TSLA)
Vanguard Specialized Funds Div App Etf (VIG)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
JPMorgan Chase & Co. (JPM)

View all positions for Vanguard Global Advisers

Top funds holding Lenz Therapeutics

RA Capital Management
FMR
Falcon Edge Capital
Versant Venture Management
BlackRock
Squarepoint Ops
Vanguard Group
Standard Life Aberdeen
Franklin Resources
Vanguard Capital Management
72 Investment Holdings
Millennium Management
CAM Group Holding A/S
Morgan Stanley
Bank of America Corporation

View all funds holding Lenz Therapeutics